Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Trichotillomania treatment is most successful with a mix of behavioral therapy, medication, and social support.

The review found that individualized treatment and teamwork are important for trichotillomania, and patients who followed through with treatment often improved.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Photobiomodulation improves the quality of life for people with hair loss.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Inner city teens had high retention rates for the contraceptive implant, especially those with a history of abortion.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Women with PCOS have more emotional and body image issues than healthy women.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Pranic meditation significantly improved mental health and quality of life for breast cancer survivors.

The medication lopinavir-ritonavir may cause severe hair loss.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.